Probably so, but the delay has nothing to do with any problem they are encountering with their technology or anything fundamental. Traders will get antsy and will exit, but it just provides a good buying opportunity for us. Nothing fundamental has changed with the company at all. Sales are still coming. The FDA EUA seems like it will not happen until some time next year, but that is not due to any fault of the company itself. It will mean more if they get it because of the new regulations that make it more meaningful. The revenue potential is still there. A little patience will pay off nicely!
News 
Market Data 
Discover 
